Manufacturers Life Insurance Company, The Terns Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 24,378 shares of TERN stock, worth $88,979. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,378
Previous 66,100
63.12%
Holding current value
$88,979
Previous $551,000
75.32%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TERN
# of Institutions
160Shares Held
83.9MCall Options Held
473KPut Options Held
119K-
Soleus Capital Management, L.P. Greenwich, CT8.14MShares$29.7 Million3.16% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$27.6 Million1.14% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$25.2 Million7.51% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$20.4 Million1.37% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.75MShares$17.3 Million0.17% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $137M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...